September 27, 2021

Monday

Why you’re not getting a delta-specific booster yet (vox.com)

With mRNA vaccines, the science of an update to the latest "variant of concern" is probably the easy part. That's one of the major benefits of the technology over old-school vaccines. But, in the midst of a pandemic, limited regulatory review resources and manufacturing capacity are powerful forces for holding off on new versions...for now.

tags: covid19vaccine

link published in /2021/09/27